Filing Details
- Accession Number:
- 0001387131-18-002844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-26 16:53:36
- Reporting Period:
- 2014-04-10
- Accepted Time:
- 2018-06-26 16:53:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1119643 | Nutra Pharma Corp | NPHC | Medicinal Chemicals & Botanical Products (2833) | 912021600 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1266490 | J Rik Deitsch | 12538 W. Atlantic Blvd. Coral Springs FL 33071 | President, Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Nutra Pharma Corp Common Stock | Acquisiton | 2014-04-10 | 1,250,000 | $0.08 | 4,791,959 | No | 4 | P | Direct | |
| Nutra Pharma Corp Common Stock | Acquisiton | 2014-12-11 | 506,900 | $0.24 | 5,298,859 | No | 4 | A | Direct | |
| Nutra Pharma Corp Common Stock | Acquisiton | 2015-06-13 | 4,000,000 | $0.19 | 9,298,859 | No | 4 | A | Direct | |
| Nutra Pharma Corp Common Stock | Acquisiton | 2016-06-28 | 4,000,000 | $0.01 | 13,298,859 | No | 4 | A | Direct | |
| Nutra Pharma Corp Common Stock | Acquisiton | 2016-07-05 | 15,000,000 | $0.01 | 28,298,859 | No | 4 | P | Direct | |
| Nutra Pharma Corp Common Stock | Acquisiton | 2016-12-19 | 15,000,000 | $0.01 | 43,298,859 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Series A Preferred | Nutra Pharma Series A Preferred | Acquisiton | 2017-10-30 | 3,000,000 | $0.13 | 3,000,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,000,000 | No | 4 | A | Direct |
Footnotes
- Preferred shares have no right of conversion and are valued at $0.133 per share, which represents the actual cost paid. The Series A Preferred Stock will vote with the Corporation's common stock as a single class on all matters or consents for the Corporation's common stockholders. Each share of Series A Preferred Stock is entitled to one thousand votes per share.
Billionaire Hedge Funds
